Table of Contents: 2021 JULY–AUGUST No. 441
RxNorm July 2021 Release. NLM Tech Bull. 2021 Jul-Aug;(441):b1.
The RxNorm July monthly release became available for download on Tuesday, July 6, 2021. It includes two new COVID-19-related clinical drug concepts. See below for more details.
RXNORM DATA CHANGES
Two New COVID-19-Related Concepts Added
First, sotrovimab, a drug allowed under the U.S. Food & Drug Administration Emergency Use Authorization (EUA), became available in the RxNorm June 9, 2021 weekly release and is included in the RxNorm July 2021 monthly release.
Here is the sotrovimab Semantic Clinical Drug (SCD) name, RxNorm Concept Unique Identifier (RXCUI), and National Drug Code (NDC):
Second, a propofol lipid emulsion product was also added. This product is an investigational infusion to maintain sedation in patients 16 or older who require mechanical ventilation in an Intensive Care Unit (ICU) setting during the 2019 coronavirus disease (COVID-19) pandemic.
Here is the new propofol lipid emulsion Semantic Clinical Drug (SCD) name, RxNorm Concept Unique Identifier (RXCUI), and National Drug Code (NDC):
The COVID-19 Vaccines and Medications in RxNorm page lists all the COVID-19 related clinical drug products in RxNorm.
NOTICE OF UPCOMING DATA CHANGES
As a courtesy to users, this section provides advance notice of possible upcoming RxNorm data changes. More information about each change will be provided or repeated in the future. Please note that planned data changes and timelines may change if issues arise.
Several BoSS attributes are planned to change this fall. A specific month is not available, but is likely to occur September 2021 at the earliest. Below are more details. Please plan accordingly.
